Under pressure over rising drug prices, pharmaceutical companies are pushing a new defense: They’re not raising prices to make money or to cover research costs, but rather to pay a cut to middlemen in the supply chain.
from WSJ.com: What's News US https://on.wsj.com/2Se0Woj
Subscribe to:
Post Comments (Atom)
-
By BY NEW YORK TIMES AUDIO from NYT Podcasts https://ift.tt/8Zjh7kA
-
By BY EITAN D. HERSH from NYT Opinion https://ift.tt/38L2rhL
-
By BY NEW YORK TIMES AUDIO from NYT Podcasts https://ift.tt/MAm51p4
No comments:
Post a Comment